Literature DB >> 30064530

Meeting the Challenges of International Crises: The Experience of the Iranian Blood Transfusion Organization.

Nasim Sadat Hosseini Divkolaye1, Fariba Seighali2, Ali Akbar Pourfathollah2, Mitra Radfar3, Frederick M Burkle4.   

Abstract

ABSTRACTCrises require a timely and well-prepared response by health services, especially those that are directly engaged with the lives of the patients such as blood services. The Iranian Blood Transfusion Organization as a single national authority of blood transfusion has left many crises behind. In this study, we examined the main international crises that the blood transfusion organization has faced during its 44-year history and objectively evaluated the methods for crisis risk reduction, both administrative and operational, all of which have led to fundamental advances in the organization. By proper planning and effective strategy setting, the Iranian Blood Transfusion Organization has managed to cope with international threats and in some cases has turned threats into opportunities to implement new, permanent administrative and operational strategies. It is not prudent for blood transfusion centers to develop their disaster risk reduction strategies on an individual-country basis in a world where global risk and crisis factors are rapidly increasing. Reduction of risk for blood transfusion centers must become a strategic priority nationally and globally. (Disaster Med Public Health Preparedness. 2019;13:410-413).

Entities:  

Keywords:  HIV; Iran-Iraq War; blood donation; blood transfusion; crisis management; disaster medicine; hepatitis; recruitment campaign

Mesh:

Year:  2018        PMID: 30064530     DOI: 10.1017/dmp.2018.71

Source DB:  PubMed          Journal:  Disaster Med Public Health Prep        ISSN: 1935-7893            Impact factor:   1.385


  1 in total

1.  Coronavirus disease 2019 (COVID-19) and decrease in blood donation: experience of Iranian Blood Transfusion Organization (IBTO).

Authors:  Saeed Mohammadi; Seyed Morteza Tabatabaei Yazdi; Peyman Eshghi; Amir Hossein Norooznezhad
Journal:  Vox Sang       Date:  2020-04-20       Impact factor: 2.144

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.